6,928 Shares in Addus HomeCare Co. (NASDAQ:ADUS) Bought by Redhawk Wealth Advisors Inc.

Redhawk Wealth Advisors Inc. bought a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 6,928 shares of the company’s stock, valued at approximately $922,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. UMB Bank n.a. boosted its stake in Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after purchasing an additional 88 shares during the last quarter. Quest Partners LLC acquired a new stake in Addus HomeCare during the 2nd quarter worth $31,000. EntryPoint Capital LLC acquired a new position in shares of Addus HomeCare during the 1st quarter valued at about $44,000. Innealta Capital LLC acquired a new position in shares of Addus HomeCare during the 2nd quarter valued at about $44,000. Finally, GAMMA Investing LLC boosted its position in shares of Addus HomeCare by 40.8% during the 1st quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after acquiring an additional 161 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $131.81 on Tuesday. The firm’s 50-day moving average is $129.83 and its two-hundred day moving average is $117.54. Addus HomeCare Co. has a 12 month low of $78.35 and a 12 month high of $136.12. The stock has a market capitalization of $2.39 billion, a P/E ratio of 32.71, a PEG ratio of 2.33 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. The company had revenue of $286.90 million for the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.94 earnings per share. As a group, analysts anticipate that Addus HomeCare Co. will post 4.58 EPS for the current year.

Insiders Place Their Bets

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the sale, the director now directly owns 3,866 shares in the company, valued at $502,695.98. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the sale, the director now owns 3,866 shares in the company, valued at $502,695.98. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 22,917 shares of company stock worth $3,050,082 over the last three months. Company insiders own 4.60% of the company’s stock.

Analysts Set New Price Targets

ADUS has been the topic of several recent research reports. Royal Bank of Canada reissued an “outperform” rating and set a $141.00 price target on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Oppenheimer boosted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. StockNews.com cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Macquarie reissued an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Friday. Finally, Stephens reissued an “overweight” rating and set a $138.00 price target on shares of Addus HomeCare in a research report on Tuesday, August 6th. One analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $131.38.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.